Abstract
Bisphenol A (BPA) is a high volume production chemical used in the manufacture of polycarbonate plastics and epoxy resins. Recent experimental studies have suggested that BPA affects glucose metabolism through diverse mechanisms including insulin resistance, pancreatic β-cell dysfunction, adipogenesis, inflammation and oxidative stress. Prediabetes is a stage earlier in the hyperglycemia continuum associated with increased future risk of developing diabetes. Therefore, we examined the association between BPA exposure and prediabetes among subjects free of diabetes. We examined the association between urinary BPA levels and prediabetes in 3,516 subjects from the National Health and Nutritional Examination Survey 2003–2008. Urinary BPA levels were examined in tertiles. Prediabetes was defined as fasting glucose concentration 100–125 mg/dL or 2-h glucose concentration of 140–199 mg/dL or an A1C value of 5.7–6.4 %. Overall, we observed a positive association between higher levels of urinary BPA and prediabetes, independent of potential confounders including body mass index, alcohol intake, blood pressure and serum cholesterol levels. Compared to tertile 1 (referent), the multivariate-adjusted odds ratio (95 % confidence interval) of prediabetes associated with tertile 3 of BPA was 1.34 (1.03–1.73), p-trend = 0.02. In subgroup analysis, this association was stronger among women and obese subjects. Higher urinary BPA levels are found to be associated with prediabetes independent of traditional diabetes risk factors. Future prospective studies are needed to confirm or disprove this finding.
Similar content being viewed by others
References
Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391–395
Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24:139–177
Adachi T, Yasuda K, Mori C et al (2005) Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. Food Chem Toxicol 43:713–719
Sakurai K, Kawazuma M, Adachi T et al (2004) Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 141:209–214
Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A (2006) The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106–112
Gerich JE (2003) Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447–456
Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A (2008) Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31:194–200
Kawasaki T, Igarashi K, Ogata N, Oka Y, Ichiyanagi K, Yamanouchi T (2010) Markedly increased serum and urinary fructose concentrations in diabetic patients with ketoacidosis or ketosis. Acta Diabetol 49:119–123
Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310
Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS (2010) Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 5:e8673
American Diabetes Association (2010) Standards of medical care in diabetes–2010. Diabetes 413 Care 33 (suppl 1):S11–S61
Leiter LA (2006) From hyperglycemia to the risk of cardiovascular disease. Rev Cardiovasc Med 7(Suppl 2):S3–S9
Gabir MM, Hanson RL, Dabelea D et al (2000) Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23:1113–1118
Schaefer C, Biermann T, Schroeder M et al (2010) Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia. Acta Diabetol 47:19–27
Zheng X, Ren W, Zhang S et al (2010) Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus. Acta Diabetol 47:265–270
Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139
National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: survey operations manuals (Article online)
National Center for Health Statistics (2010) 2005–2006 National Health and Nutrition Examination Survey: survey operations manuals (Article online)
National Center for Health Statistics (2010) 2007–2008 National Health and Nutrition Examination Survey: survey operations manuals (Article online)
National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: survey operations manuals (Article online). Available at: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/current_nhanes_03_04.htm. Accessed 22 April 2011
National Center for Health Statistics (2010) 2005–2006 National Health and Nutrition Examination Survey: survey operations manuals (Article online). Available at: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/current_nhanes_05_06.htm. Accessed 22 April 2011
National Center for Health Statistics (2010) 2007–2008 National Health and Nutrition Examination Survey: survey operations manuals (Article online). Available at: http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/current_nhanes_07_08.htm. Accessed 22 April 2011
National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: Laboratory procedures (Article online). Available at: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/L24EPH_C.htm. Accessed 4 May 2011
National Center for Health Statistics (2009) 2005–2006 National Health and Nutrition Examination Survey: Environmental phenols and parabens (EPH_D). Available at: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/EPH_D.htm. Accessed 24 October 2011
Ye X, Kuklenyik Z, Needham LL, Calafat AM (2005) Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem 77:5407–5413
National Center for Health Statistics (2010) 2003–2004 National Health and Nutrition Examination Survey: laboratory procedures (Article online)
Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34(suppl 1):S62–S69
Kehoe R, Wu SY, Leske MC, Chylack LT Jr (1994) Comparing self-reported and physician-reported medical history. Am J Epidemiol 139:813–818
Szklo M, Nieto FJ (2007) Epidemiology: beyond the basics
Rubin BS, Soto AM, Bisphenol A (2009) Perinatal exposure and body weight. Mol Cell Endocrinol 304:55–62
Guo L, Cheng Y, Wang X et al (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol 49:S65–S71
Ben-Jonathan N, Hugo ER, Brandebourg TD (2009) Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol 304:49–54
Bindhumol V, Chitra KC, Mathur PP (2003) Bisphenol A induces reactive oxygen species generation in the liver of male rats. Toxicology 188:117–124
Kim MJ, Jung HS, Hwang-Bo Y et al (2011) Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta Diabetol [Epub ahead of print]
Wada K, Sakamoto H, Nishikawa K et al (2007) Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J Pharmacol Sci 105:133–137
Sargis RM, Johnson DN, Choudhury RA, Brady MJ (2010) Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 18:1283–1288
Moriyama K, Tagami T, Akamizu T et al (2002) Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185–5190
Teeguarden JG, Calafat AM, Ye X et al (2011) Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci 123:48–57
Hengstler JG, Foth H, Gebel T et al (2011) Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Crit Rev Toxicol 41:263–291
Tsukioka T, Terasawa J, Sato S, Hatayama Y, Makino T, Nakazawa H (2004) Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J Environ Chem 14:57–63
Fernandez MF, Arrebola JP, Taoufiki J et al (2007) Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 24:259–264
Nunez AA, Kannan K, Giesy JP, Fang J, Clemens LG (2001) Effects of bisphenol A on energy balance and accumulation in brown adipose tissue in rats. Chemosphere 42:917–922
Carwile JL, Michels KB (2011) Urinary bisphenol A and obesity: NHANES 2003–2006. Environ Res 111:825–830
Thorand B, Baumert J, Kolb H et al (2007) Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Diabetes Care 30:854–860
Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288–1299
Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL (2008) Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ Health Perspect 116:39–44
Mahalingaiah S, Meeker JD, Pearson KR et al (2008) Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect 116:173–178
Braun JM, Kalkbrenner AE, Calafat AM et al (2011) Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect 119:131–137
Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM Jr (2000) The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 54:3–18
Ye X, Wong LY, Bishop AM, Calafat AM (2011) Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 119:983–988
WHO/FAO Expert Panel (2011) Toxicological and Health Aspects of Bisphenol A. Available at: http://whqlibdoc.who.int/publications/2011/97892141564274_eng.pdf. Accessed 26 Sep 2011
Schulze MB, Manson JE, Ludwig DS et al (2004) Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 292:927–934
Acknowledgments
This study was funded by an American Heart Association National Clinical Research Program grant (AS).
Conflict of interest
There are no conflicts of interest related to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sabanayagam, C., Teppala, S. & Shankar, A. Relationship between urinary bisphenol A levels and prediabetes among subjects free of diabetes. Acta Diabetol 50, 625–631 (2013). https://doi.org/10.1007/s00592-013-0472-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-013-0472-z